Focus Features has secured the U.S. and multiple international rights to "Elsinore," the biographical drama about late actor Ian Charleson, starring Andrew Scott and Olivia Colman. Directed by Simon Stone and written by Stephen Beresford, the film chronicles Charleson's final months as he performed Hamlet at London's National Theatre while privately living with AIDS. Charleson, best known for his role as Olympic runner Eric Liddell in "Chariots of Fire," died in January 1990 at age 40, weeks after the production ended. Scott, an Emmy and Golden Globe nominee for "Ripley" and a BAFTA nominee for "All of Us Strangers," plays Charleson and serves as producer. Colman portrays the doctor who treated him during his illness.
The ensemble cast includes Billie Piper, Johnny Flynn, Luke Thompson, Monica Dolan, Juliet Stevenson, Joe Locke, Adeel Akhtar, Matthew Beard, David Dawson as filmmaker Derek Jarman, Kadiff Kirwan, Dickie Beau and Peter Mullan. Producers include Andrea Occhipinti of Lucky Red, Gaby Tana of Magnolia Mae Films, Pete Shilaimon, Mickey Liddell of LD Entertainment, Stefano Massenzi and Carolyn Marks Blackwood. The film was shot across the U.K. earlier this year under StudioCanal, LD Entertainment, Lucky Red and Magnolia Mae Films. Mike Eley serves as cinematographer, with Valerio Bonelli as editor.
Focus Features plans a fall release and is positioning "Elsinore" for a major festival premiere, with Venice, Telluride, Toronto and New York all reportedly interested. No premiere venue has been confirmed. Early reactions from those who have seen the film describe overwhelming praise for Scott's performance. The acquisition marks a key addition to Focus Features' awards slate, which already includes the breakout horror film "Obsession" by debut director Curry Barker, the studio's highest-grossing release to date. A "Sense and Sensibility" remake is also upcoming.
Andrew Scott plays a dying actor hiding his illness while delivering a defining performance, yet the film's own condition remains unseen. Focus Features is betting on acclaim for a movie no festival has officially selected. The studio's gamble hinges on praise from unnamed sources rather than public screenings or confirmed placements. Awards momentum is being built on whispers, not showings.
Editorial note: AI-assisted opinion, not established fact. Full disclaimer →
